Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis
- PMID: 36774332
- PMCID: PMC9905096
- DOI: 10.1016/j.vaccine.2023.02.008
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis
Abstract
Background: The relationship between coronavirus disease 2019 (COVID-19) vaccination and long COVID has not been firmly established. We conducted a systematic review and meta-analysis to evaluate the association between COVID-19 vaccination and long COVID.
Methods: PubMed and EMBASE databases were searched on September 2022 without language restrictions (CRD42022360399) to identify prospective trials and observational studies comparing patients with and without vaccination before severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We also included studies reporting symptomatic changes of ongoing long COVID following vaccination among those with a history of SARS-CoV-2 infection. Odds ratios (ORs) for each outcome were synthesized using a random-effects model. Symptomatic changes after vaccination were synthesized by a one-group meta-analysis.
Results: Six observational studies involving 536,291 unvaccinated and 84,603 vaccinated (before SARS-CoV-2 infection) patients (mean age, 41.2-66.6; female, 9.0-67.3%) and six observational studies involving 8,199 long COVID patients (mean age, 40.0 to 53.5; female, 22.2-85.9%) who received vaccination after SARS-CoV-2 infection were included. Two-dose vaccination was associated with a lower risk of long COVID compared to no vaccination (OR, 0.64; 95% confidence interval [CI], 0.45-0.92) and one-dose vaccination (OR, 0.60; 95% CI, 0.43-0.83). Two-dose vaccination compared to no vaccination was associated with a lower risk of persistent fatigue (OR, 0.62; 95% CI, 0.41-0.93) and pulmonary disorder (OR, 0.50; 95% CI, 0.47-0.52). Among those with ongoing long COVID symptoms, 54.4% (95% CI, 34.3-73.1%) did not report symptomatic changes following vaccination, while 20.3% (95% CI, 8.1-42.4%) experienced symptomatic improvement after two weeks to six months of COVID-19 vaccination.
Conclusions: COVID-19 vaccination before SARS-CoV-2 infection was associated with a lower risk of long COVID, while most of those with ongoing long COVID did not experience symptomatic changes following vaccination.
Keywords: COVID-19; Long COVID; Post-acute sequelae of COVID-19; SARS-CoV-2; Vaccine.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9905096/bin/gr1_lrg.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9905096/bin/gr2_lrg.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9905096/bin/gr3_lrg.gif)
Similar articles
-
Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review and Meta-analysis.JAMA Pediatr. 2023 Apr 1;177(4):384-394. doi: 10.1001/jamapediatrics.2022.6243. JAMA Pediatr. 2023. PMID: 36689319 Free PMC article.
-
Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2022 Sep 29;19(19):12422. doi: 10.3390/ijerph191912422. Int J Environ Res Public Health. 2022. PMID: 36231717 Free PMC article. Review.
-
Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients.Clin Microbiol Infect. 2022 Aug;28(8):1140-1148. doi: 10.1016/j.cmi.2022.03.016. Epub 2022 Mar 23. Clin Microbiol Infect. 2022. PMID: 35339673 Free PMC article.
-
15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study.Front Immunol. 2023 Sep 12;14:1226622. doi: 10.3389/fimmu.2023.1226622. eCollection 2023. Front Immunol. 2023. PMID: 37781408 Free PMC article.
-
COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis.Brain Behav Immun. 2023 Jul;111:211-229. doi: 10.1016/j.bbi.2023.03.022. Epub 2023 Mar 27. Brain Behav Immun. 2023. PMID: 36990297 Free PMC article. Review.
Cited by
-
The prevalence of long COVID-19 syndrome in hospitalized patients with COVID-19 pneumonia.Infez Med. 2024 Jun 1;32(2):202-212. doi: 10.53854/liim-3202-8. eCollection 2024. Infez Med. 2024. PMID: 38827835 Free PMC article.
-
Clinical coding of long COVID in primary care 2020-2023 in a cohort of 19 million adults: an OpenSAFELY analysis.EClinicalMedicine. 2024 May 17;72:102638. doi: 10.1016/j.eclinm.2024.102638. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38800803 Free PMC article.
-
Long-Term Impairment of Working Ability in Subjects under 60 Years of Age Hospitalised for COVID-19 at 2 Years of Follow-Up: A Cross-Sectional Study.Viruses. 2024 Apr 26;16(5):688. doi: 10.3390/v16050688. Viruses. 2024. PMID: 38793570 Free PMC article.
-
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach.Diseases. 2024 May 6;12(5):95. doi: 10.3390/diseases12050095. Diseases. 2024. PMID: 38785750 Free PMC article. Review.
-
Predictors of somatic symptoms during the COVID-19 pandemic: a national longitudinal survey in Japan.BMJ Open. 2024 May 7;14(5):e082439. doi: 10.1136/bmjopen-2023-082439. BMJ Open. 2024. PMID: 38719316 Free PMC article.
References
-
- World Health Organization. WHO Coronavirus (COVID-19) Dashboard. WHO Coronavirus (COVID-19) Dashboard 2022. https://covid19.who.int/ (accessed March 10, 2022).
-
- Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., et al. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021;8 doi: 10.1016/j.lanepe.2021.100186. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous